为了正常的体验网站,请在浏览器设置里面开启Javascript功能!

【word】 海肤康HYPHENCAN

2017-12-20 3页 doc 17KB 12阅读

用户头像

is_421808

暂无简介

举报
【word】 海肤康HYPHENCAN【word】 海肤康HYPHENCAN 海肤康HYPHENCAN ? 698?2007年9月第27卷第9期ChinJOrthop—ber22!:22: nousthromboembolicdiseasefollowingprimarytotalkneearthro— plasty.Arandomized,muhicenter,open—tabel,parallel—groupcom— parlsonofenoxaparinandwarfarin.JBoneJointSurg(Am),2001,83: 900—90...
【word】 海肤康HYPHENCAN
【word】 海肤康HYPHENCAN 海肤康HYPHENCAN ? 698?2007年9月第27卷第9期ChinJOrthop—ber22!:22: nousthromboembolicdiseasefollowingprimarytotalkneearthro— plasty.Arandomized,muhicenter,open—tabel,parallel—groupcom— parlsonofenoxaparinandwarfarin.JBoneJointSurg(Am),2001,83: 900—906. 1lSongEK,KimJK,LeeKB,eta1.Deepveinthrombosisaftertotal kneereplacement.Incidenceandcorrelationwithclinicalriskfac— tots.JKoreanKneeSoc,1998,10:l8—22. 12FujitaS,HirotaS,OdaT,eta1.Deepvenousthrombosisaftertotal hiporkneearthroplastyinpatientsinJapan.ClinOrthopRelatRes, 2000,(375):168-174. 13WangCJ,WangJW,ChenLM,eta1.Deepveinthrombosisafterto— talkneearthroplasty.JFormosMedAssoc,2000,99:848-853. 14FongYK,RubanP,YeoSJ,eta1.Useoflowmolecularweighthep- arinforpreventionofdeepveinthrombosisintotalkneearthroplas— ty一一astudyofitsefficacyinanAsianpopulation.AnnAcadMed Singapore.2000.29:439—441. 15KimYH,KimJS.Incidenceandnaturalhistoryofdeep—veinthrom— bosisaftertotalkneearthroplasty.Aprospective,randomisedstudy. JBoneJointSurg(Sr),2002,84:566-570. 16吕厚山.人工关节置换术后下肢DVT形成.中华骨科杂志,1993, l3:l55一l56. 17邱贵兴,杨庆铭,余楠生,等.低分子肝素预防髋,膝关节手术后下 肢深静脉血栓形成的多中心研究.中华骨科杂志,2006,26:819— 822. 18HanssonPO,WelinL,TibblinG,eta1.Deepveinthrombosisand pulmonaryembolisminthegeneralpopulation.’TheStudyofMen Bornin1913’.ArchInternMed,1997,157:1665—1670. 19KniffinWDJr,BaronJA,BarrettJ,eta1.Theepidemiologyofdiag— nosedpulmonaryembolismanddeepvenousthrombosisintheelder- ly.ArchInternMed,1994,154:861—866. 2OSilversteinMD,HeitJA,MohrDN,eta1.Trendsintheincidenceof deepveinthrombosisandpulmonaryembolism:a25一yearpopula- tion—basedstudy.ArchInternMed.1998.158:585—593. 21ThomasDP.RobertsHR.Hypercoagulabilityinvenousandarterial thrombosis.AnnInternMed.1997.126:638—644. 22PriceDT,RidkerPM.FactorVLeidenmutationandtherisksfor thromboembolicdisease:aclinicalperspective.AnnInternMed, 1997,127:895-903. 23RidkerPM,MiletichJP,HennekensCH,eta1.Ethnicdistributionof factorVLeidenin4047menandwomen.Implicationsforvenous thromboembolismscreening.JAMA,1997,277:1305—1307. 24ReesDC,CoxM,CleggJB.WorlddistributionoffactorVLeiden. Lancet.1995.346:l133一l134. 25GreggJP,YamaneAJ,GrodyWW.PrevalenceofthefactorV—Lei— denmutationinfourdistinctAmericanethnicpopulations.AmJ MedGenet,1997,73:334—336. 26FrancoRF,ReitsmaPH.Geneticriskfactorsofvenousthrombosis. HumGenet.2o01.109:369—384. 27IsoH,FolsomAR,WuKK,eta1.HemostaticvariablesinJapanese Caucasianmen.Plasmafibrinogen,factorVIIc,factorVIIlc,andvon Willebrandfactorandtheirrelationstocardiovasculardiseaserisk factors.AmJEpidemiol,1989,130:925—934. 28LeizoroviczA,TurpieAG,CohenAT,eta1.Epidemiologyofvenous thromboembolisminAsianpatientsundergoingmajororthopedic surgerywithoutthromboprophylaxis.TheSMARTstudy.JThromb Haemost.2oo5.3:28—34. 29FletcherJP,KershawLZ,BarkerDS,eta1.Ultrasounddiagnosisof lowerlimbdeepvenousthrombosis.MedJAust,1990,153:453— 455. (收稿日期:2007—07—05) (本文编辑:马宏庆)
/
本文档为【【word】 海肤康HYPHENCAN】,请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑, 图片更改请在作品中右键图片并更换,文字修改请直接点击文字进行修改,也可以新增和删除文档中的内容。
[版权声明] 本站所有资料为用户分享产生,若发现您的权利被侵害,请联系客服邮件isharekefu@iask.cn,我们尽快处理。 本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用。 网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。

历史搜索

    清空历史搜索